Skip to main content
. Author manuscript; available in PMC: 2013 Aug 1.
Published in final edited form as: Hum Immunol. 2012 May 17;73(8):783–787. doi: 10.1016/j.humimm.2012.05.006

Table 4.

Analysis of KIR3DS1 and HLA-Bw480I Influence on Disease Outcome in a Japanese HTLV-1 Cohort
AS HAM/TSP
n % n % Odds Ratio [95% CI] P Value
3DS1 180 37.8 222 36.5 1.19 [0.71–2.01] 0.5
Bw480I 180 35.6 222 39.6 0.79 [0.47–1.32] 0.37
3DS1+ Bw480I 180 13.9 222 13.5 1.44 [0.71–2.9] 0.3